These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34004254)
1. Comparative effects of incretin-based therapy on early-onset diabetic nephropathy in rats: Role of TNF-α, TGF-β and c-caspase-3. Habib HA; Heeba GH; Khalifa MMA Life Sci; 2021 Aug; 278():119624. PubMed ID: 34004254 [TBL] [Abstract][Full Text] [Related]
2. Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats. Habib HA; Heeba GH; Khalifa MMA Eur J Pharmacol; 2021 Feb; 892():173721. PubMed ID: 33159934 [TBL] [Abstract][Full Text] [Related]
3. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats. Maheshwari RA; Balaraman R; Sen AK; Seth AK Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335 [TBL] [Abstract][Full Text] [Related]
4. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats. Ahmed OM; Ali TM; Abdel Gaid MA; Elberry AA PLoS One; 2019; 14(9):e0214349. PubMed ID: 31527864 [TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes. Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619 [TBL] [Abstract][Full Text] [Related]
6. Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats. Abdel-Latif RG; Ahmed AF; Heeba GH Life Sci; 2020 Dec; 263():118592. PubMed ID: 33065146 [TBL] [Abstract][Full Text] [Related]